Results 101 to 110 of about 2,485 (155)

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes

Drug Design, Development and Therapy, 2017
Fernando Notario-Pérez, Roberto Ruiz-Caro, María-Dolores Veiga-Ochoa Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain Abstract: Infection with human ...
Notario-Pérez F, Ruiz-Caro R, Veiga-Ochoa MD   +2 more
doaj  

Intravaginal immunization using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses [PDF]

, 2017
Aldon, Yoann, Kett, Vicky, King, Deborah, Malcolm, R Karl, Mann, Jamie F S, McKay, Paul F, Pattani, Aditya, Shattock, Robin J   +7 more
core   +1 more source

J Infect Dis [PDF]

High rates of tuberculosis transmission are driving the ongoing global tuberculosis epidemic, and there is a pressing need for research focused on understanding and, ultimately, halting transmission. The ongoing tuberculosis-human immunodeficiency virus (

core  

The Current and Future Impact of WHO Guidance on Global HIV Pre-Exposure Prophylaxis Programs: A Narrative Review. [PDF]

Infect Drug Resist
Mishriky F, Chan PA.
europepmc   +1 more source

Values and preferences of female sex workers in Zimbabwe for long-acting injectable pre-exposure prophylaxis and the dapivirine vaginal ring: results of a mixed-methods research study. [PDF]

BMJ Glob Health
Machingura F, d'Elbée M, Kujeke T, Maguma J, Rodolph M, Baggaley R, Chabata ST, Cowan FM.   +7 more
europepmc   +1 more source

Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. [PDF]

J Acquir Immune Defic Syndr
Friedland BA, Browne EN, Roberts ST, Ngure K, Nakalega R, Macdonald P, Mpongo CN, Tenza S, Mhlanga N, Szydlo D, Johnson S, McClure T, Nair G, Celum C, Hillier SL, van der Straten A, MTN-034 REACH clinical trial team.   +16 more
europepmc   +1 more source

Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. [PDF]

J Natl Cancer Inst
Hathaway CL, Brown ER, Cherne S, Sepulveda AL, Chirenje ZM, Jeenarain N, Naidoo L, Siva S, Singh N, Woeber K, Gaffoor Z, Mirembe BG, Kiweewa FM, Mansoor LE, Chinula L, Dadabhai S, Mugo NR, Palanee-Phillips T, Barnabas RV.   +18 more
europepmc   +1 more source

Use of Pharmacokinetic Data in Novel Analyses to Determine the Effect of Topical Microbicides as Preexposure Prophylaxis Against HIV Infection. [PDF]

, 2015
Vermund, SH, Walker, AS
core   +1 more source

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. [PDF]

Lancet HIV, 2023
Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabiito C, Bekker LG, Siziba B, Hillier SL, Baeten JM, Garcia M, Johnson S, McClure T, Levy L, Livant E, Jacobson C, Soto-Torres L, van der Straten A, Hosek S, Rooney JF, Steytler J, Bunge K, Parikh U, Hendrix C, Anderson P, Ngure K, REACH Protocol Team.   +33 more
europepmc   +1 more source

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial. [PDF]

Lancet HIV
Noguchi LM, Owor M, Mgodi NM, Gati Mirembe B, Dadabhai S, Horne E, Gundacker H, Richardson BA, Bunge K, Scheckter R, Song M, Marzinke MA, Anderson PL, Livant E, Jacobson C, Piper JM, Chakhtoura N, Hillier SL, Balkus JE, MTN-043 Study Team.   +19 more
europepmc   +1 more source